AzTrials
AzTrials

Cases Who Received TKA/THANCT05685706

Knee-Hip-Spine Harmony: The Relationship Between Sagittal Spinal Alignment in Total Hip/Knee Arthroplasty

An observational study of Cases Who Received TKA/THA, run by China Medical University Hospital at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Concomitant osteoarthritis of hip/knee joint and lumbar spinal degeneration is commonly seen in elderly population. These degeneration changes of spine would change sagittal or coronal alignment and spinal flexibility in varies degrees. Read more about this study

Who is it for?
Any age
Conditions the study is for
Cases Who Received TKA/THA
How many people
300 participants
Where
1 siteTaiwan
Study dates
7 Jul 2021to 31 Dec 2031
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Concomitant osteoarthritis of hip/knee joint and lumbar spinal degeneration patients who take Total hip and knee arthroplasty

Who may be able to join

  • Primary degenerative arthritis of the knee or hip
  • Those who have undergone artificial knee or hip replacement surgery
  • Follow up surgery for at least 1 year
  • Track the whole trunk lower limb sagittal plane coronal aligament before and after surgery

Who cannot join

  • Previous hip surgery
  • Previous spine surgery
  • Contracture after hip fusion surgery
  • Scoliosis over 10 degrees combined with neuropathy
  • Patients with flexion contracture after knee joint surgery
  • Rheumatoid arthritis lesions

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site, 1 recruiting
  • China Medical University Hospital

    Taichung, North District, 404327

    Chun-Hao Tsai, PhD, 04-22052121 ext. 5052, ritsai8615@gmail.com

    Yu-Han Chang, +886 0909 507 981, arthrokneecmuh@gmail.com

    Recruiting

Other trials in Taiwan

About this study

Concomitant osteoarthritis of hip/knee joint and lumbar spinal degeneration is commonly seen in elderly population. These degeneration changes of spine would change sagittal or coronal alignment and spinal flexibility in varies degrees. Total hip and knee arthroplasty (THA/TKA) are among the most successful orthopedic operations performed, aiming at the alleviation of osteoarthritic pain. Normal alignment of the spine and pelvis in the sagittal plane is critical to maintain an upright standing position with minimal energy consumption. However, there is a scarcity of studies on how THA or TKA influences the parameters of the spine and the pelvis.

Compared with the balance of coronal plane, more attention is paid to the balance of sagittal plane. The objectives of this study are to investigate changes in the truncal parameters after THA or TKA and assess whether these parameters are improved or deteriorated after these operations.

Keywords
Total hip/knee arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Forgotten Joint Score-12 (FJS-12)

    The Forgotten Joint Score-12 (FJS-12) is a validated patient-reported outcome measure (PROM) tool designed to assess artificial prosthesis awareness during daily activities following total hip arthroplasty (THA). The Forgotten Joint Score consists of 12 questions and is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities (Rosinsky et al., 2019).

    Measured: Post-operative at 24th month

  2. EQ-5D

    EQ-5D is an instrument which evaluates the generic quality of life developed in Europe and widely used.

    Measured: Post-operative at 24th month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jan 2023
  2. Study start7 Jul 2021
  3. Primary completion31 Dec 2031 (estimated)
  4. Study completion31 Dec 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05685706
Sponsor's protocol ID
CMUH110-REC2-030
Status last verified
Jan 2023
First submitted
29 Dec 2022
Last updated
17 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cases Who Received TKA/THA, run by China Medical University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Chun-Hao Tsai, PhD (04-22052121 ext. 5052, ritsai8615@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Forgotten Joint Score-12 (FJS-12) (time frame: Post-operative at 24th month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in